Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Current Research Studies

A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

Ruxolitinib cream for Vitiligo

Phase: III
Clinicaltrials.gov ID: NCT06548360

What is the goal of the study?

Randomized, double-blind, vehicle-controlled study with an openlabel, treatment-extension period. Studying the Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Robert Sidbury
Study Team Member: Jacqueline Lee-Eng, [email protected]